Key considerations for European M&A in the life sciences sector | Practical Law

Key considerations for European M&A in the life sciences sector | Practical Law

This article illustrates how a complex and evolving legal and regulatory environment gives rise to unique challenges for those engaged in European M&A in the life sciences sector, by analysing a hypothetical M&A. In particular, it examines:

Key considerations for European M&A in the life sciences sector

Practical Law UK Articles 7-518-2124 (Approx. 19 pages)

Key considerations for European M&A in the life sciences sector

by Daniel Pavin and James Halstead*, Covington & Burling LLP
Law stated as at 01 Nov 2011European Union
This article illustrates how a complex and evolving legal and regulatory environment gives rise to unique challenges for those engaged in European M&A in the life sciences sector, by analysing a hypothetical M&A. In particular, it examines:
• A life sciences M&A case study. • Due diligence and its impact. • Intellectual property issues. • Structuring the deal. • European competition laws. • Anti-corruption laws. • Employment issues. • Tax issues.
This article is part of the PLC multi-jurisdictional guide to life sciences. For a full list of jurisdictional Q&As visit www.practicallaw.com/lifesciences-mjg.